Loading…
Fermion Oy, a subsidiary of Orion Corporation, has entered the commissioning phase of a new highly automated active pharmaceutical ingredient (API) manufacturing plant in Hanko, Finland. The investment of more than EUR 30 million will increase production capacity by approximately 50% to nearly 300 tonnes per year.
“The new, highly automated manufacturing facility equipped with state-of-the-art technology will replace the company's oldest manufacturing unit.”orionpharma.com
Summarized from public sources; check the original articles before acting on it.